EUVIMEDEUVIMED entdecken
Crossref

Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation

Huaiyang Zhong, Alec Aaron, Lindsey Hiebert, Janvier Serumondo, Yueran Zhuo, Madeline Adee, Gallican N Rwibasira, John W Ward, Jagpreet Chhatwal

Value in Health · 2024-07 · 27 (7) · 918-925

DOI: 10.1016/j.jval.2024.03.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2024-07. Verfasst von Huaiyang Zhong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Polytechnic Institute and State University, Blacksburg, VA, USA; Massachusetts General Hospital Institute for Technology Assessment, Boston,…. Hauptthemen laut MEDLINE: Hepatitis C, Disease Eradication, Feasibility Studies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: In 2018, Rwanda launched a national program to eliminate the hepatitis C virus (HCV). We aim to assess the impact of the program to date and identify strategies to achieve the World Health Organization's HCV elimination goals by 2030. METHODS: We developed a microsimulation model to simulate Rwanda's HCV epidemic from 2015 through 2050 and evaluated temporal trends in HCV infection, prevalence, mortality, and the total cost of care for scenarios that could achieve HCV elimination by 2030. RESULTS: Between 2018 and 2022, over 7 million people were screened for HCV, and 60 000 were treated. The study projected that Rwanda could achieve HCV elimination as early as 2027. A feasible strategy of an annual screening rate of 15% and a treatment rate of 100% would achieve all World Health Organization elimination goals by 2028, requiring screening an additional 4 million people and treating 23 900 patients by 2030. The elimination strategy costs $25 million for screening and diagnosis and $21 million for treatment from 2015 to 2050. The national program would avert 4900 hepatocellular carcinoma cases and 6700 HCV-related deaths and save the health system $25.33 million from 2015 to 2050. CONCLUSIONS: Rwanda is poised to become one of the first countries in the world to eliminate HCV. Rwanda's program serves as a blueprint for other countries in the African region. By rapid screening and treatment scale-up (eg, by leveraging HIV platforms) and by drug price negotiations, HCV elimination is not only feasible but can be cost-saving in low-income settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis CDisease EradicationFeasibility StudiesRwandaHumansMass ScreeningFemalePrevalenceMaleCost-Benefit AnalysisAdultMiddle AgedYoung AdultAntiviral Agents

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Virginia Polytechnic Institute and State University, Blacksburg, VA, USA; Massachusetts General Hospital Institute for Technology Assessment, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Massachusetts General Hospital Institute for Technology Assessment, Boston, MA, USA.
  • Coalition for Global Hepatitis Elimination, Task Force for Global Health, Decatur, GA, USA.
  • Ministry of Health, Rwanda Biomedical Center, Kigali, Rwanda.
  • Mississippi State University College of Business, Mississippi State, MS, USA.
  • School of Public Health, University of California Berkeley, Berkeley, CA, USA.

Förderung

  • National Science Foundation

Zitieren

APA

Zhong, H., Aaron, A., Hiebert, L., Serumondo, J., Zhuo, Y., Adee, M., Rwibasira, G. N., Ward, J. W., & Chhatwal, J. (2024). Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation. Value in Health, 27(7), 918-925. https://doi.org/10.1016/j.jval.2024.03.005

Vancouver

Zhong H, Aaron A, Hiebert L, Serumondo J, Zhuo Y, Adee M, et al. Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation. Value in Health. 2024;27(7):918-925. doi:10.1016/j.jval.2024.03.005

BibTeX
@article{Zhong2024,
  author = {Zhong, Huaiyang and Aaron, Alec and Hiebert, Lindsey and Serumondo, Janvier and Zhuo, Yueran and Adee, Madeline and Rwibasira, Gallican N and Ward, John W and Chhatwal, Jagpreet},
  title = {Hepatitis C Elimination in Rwanda: Progress, Feasibility, and Economic Evaluation},
  journal = {Value in Health},
  year = {2024},
  volume = {27},
  number = {7},
  pages = {918--925},
  doi = {10.1016/j.jval.2024.03.005}
}
Kostenlos starten →